Immune correlates of vaccine protection against HIV-1 acquisition-Reference-Cited by-同舟云学术

Immune correlates of vaccine protection against HIV-1 acquisition

Published:2015-10-21 Issue:310 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Corey Lawrence¹,Gilbert Peter B.²,Tomaras Georgia D.³,Haynes Barton F.³,Pantaleo Giuseppe⁴,Fauci Anthony S.⁵

Affiliation:

1. HIV Vaccine Trials Network, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

2. Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

3. Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.

4. Lausanne University Hospital and Swiss Vaccine Research Institute, Lausanne 1011, Switzerland.

5. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Abstract

Vaccine-induced non–broadly neutralizing antibodies are associated with protection against HIV-1 acquisition.

Funder

NIH

Bill and Melinda Gates Foundation

Duke Center for AIDS Research Immunology Core

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference59 articles.

1. High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa

2. Ten years after Dublin: principal trends in HIV surveillance in the EU/EEA, 2004 to 2013

3. Today’s HIV/AIDS Epidemic (Centers for Disease Control and Prevention Atlanta GA 2014).

4. The Gap Report (Joint United Nations Programme on HIV/AIDS Geneva 2014).

5. HIV Vaccine Development — Improving on Natural Immunity

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA-based HIV-1 vaccines;Clinical Microbiology Reviews;2024-09-12

2. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

3. Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV‐1 neutralizing antibodies;Journal of Medical Virology;2024-06

4. Insights from HIV-1 vaccine and passive immunization efficacy trials;Trends in Molecular Medicine;2024-06

5. Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection;Antibodies;2024-04-03